RougeTx: Funding, Investors & Team (Oct 2026)
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.
RougeTx has raised $58.0M across 1 funding round on record, the most recent a Series A of $58.0M announced in Oct 2026.
That round is above the $3.3M median round size for The Netherlands companies tracked on FundedIQ over the last two years.
RougeTx Company Profile and Key Stats
Latest funding round on record: Oct 2026.
RougeTx Funding Rounds
RougeTx Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
RougeTx Funding in Context
RougeTx's latest round of $58.0M is above the median round in The Netherlands. Medians cover the last 24 months of disclosed rounds.
More Funded Startups Like RougeTx
Companies Similar to RougeTx
Booomtag provides NFC, RFID, and QR-based product tagging with a cloud platform for product registration and…
Duqu provides short-term business financing by advancing money on outstanding business-to-business invoices.
Euclyd develops AI infrastructure designed to make advanced AI computing more efficient and scalable.
Persistent, forkable and suspendable virtual machines for agents and agentic workloads.
UCANACT is a digital assistive technology paired with wearables or implants to give motor-disabled…
Custodea is a data platform that brings business data from multiple software systems into one private data…
Fortaegis Technologies designs and develops semiconductors for collaborative intelligent systems.
Majoop connects jobseekers, employers, and recruiters with tools for discovery, collaboration, and automated…
AI-native back office platform automating business banking, accounting, and tax for founders.
World's first AI Hearing Health Platform
Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment…
Ore Energy develops long-duration energy storage systems for renewable energy applications and electric power…
RougeTx Funding FAQs
What does RougeTx do?
RougeTx is a biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction.
How much funding has RougeTx raised?
RougeTx has raised $58.0M across 1 round on record. The most recent is a Series A of $58.0M announced in Oct 2026.
When did RougeTx last raise funding?
RougeTx's most recent funding round on record is a Series A of $58.0M, announced in Oct 2026.
Who has invested in RougeTx?
Investors on record for RougeTx include European Investment Bank, Epidarex Capital, Kurma Partners, BioGeneration Ventures, Vesalius Biocapital Partners. FundedIQ records 10 investors in total.
Where is RougeTx headquartered?
RougeTx is based in Naarden, The Netherlands.
When was RougeTx founded?
RougeTx was founded in 2021.
About FundedIQ's RougeTx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RougeTx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.